China Delays Implementation Of Essential Drugs List; Analysts Say List Has Less Impact Than Earlier Predicted
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China's Ministry Of Health announced it will delay implementation of the Essential Drug List in 30 percent of government-controlled clinics until the end of March